19 Nov, 2024 Upcoming FDA Meeting Focuses on Generative AI in Medical Devices By Jefferson Lin The U.S. Food and Drug Administration will focus on “Total Product Lifecycle Considerations for Generative AI-Enabled Devices” during its...
18 Nov, 2024 DARPA Extends Submission Deadline for RFI By Patrick Grilli Zohra Tejani Important opportunity for investors in the defense innovation and dual-use technology sectors! The Defense Advanced Research Projects...
14 Nov, 2024 Shell Prevails in Appeal Against Landmark Climate Emissions Ruling By Wendy Grasso On Tuesday, oil and gas giant Shell won its appeal against a landmark 2021 court ruling that ordered the company to cut its absolute...
25 Oct, 2024 White House Issues Memorandum on Fostering the Safety, Security, and Trustworthiness of Artificial Intelligence By Zach Harned As required under the October 30, 2023, Executive Order 14110 on the Safe, Secure, and Trustworthy Development and Use of Artificial...
02 Oct, 2024 SEC Charges Biotech Co. with Misleading IPO Investors By Merritt Steele On September 13, the SEC charged Zymergen Inc., a biotechnology company, with misleading IPO investors about the company’s market...
30 Sep, 2024 SEC Charges Coffee Pod Co. Over Recyclability Claims By Merritt Steele On September 10, the SEC charged Keurig with making inaccurate statements regarding the recyclability of K-Cups. According to the SEC’s...
27 Sep, 2024 SEC Settles Seven Whistleblower Protection Actions By Merritt Steele On September 9, the SEC settled charges against seven public companies for violations of the whistleblower protection rule. According to...
25 Sep, 2024 Key Considerations for New Insider Trading Disclosures By Merritt Steele The following new SEC insider trading disclosures will be required in companies’ upcoming Forms 10-K (FY 2024) and/or proxy statements:...
23 Sep, 2024 California Legislature Amends Climate Disclosure Laws By Merritt Steele On August 31, the California Assembly and Senate passed SB 219, which provides for the following notable changes to the climate...
10 Sep, 2024 New Schedule 13G Filing Deadlines Looming By Merritt Steele New filing deadlines for Schedule 13G become effective on September 30. In October 2023, the SEC adopted new rules governing beneficial...
09 Sep, 2024 The Interplay of Appeals to the Federal Circuit from Both District Court and the PTAB By Jennifer Bush The recent case involving United Therapeutics' patent on Tyvaso and Liquidia's Yutrepia sheds light on the complexities of patent law....
23 Aug, 2024 SEC Announces Increased Registration Fee Rate By Merritt Steele Effective October 1, the U.S. Securities and Exchange Commission (SEC) will increase the registration fee rate from $147.60 per million...